Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity

John A. Hardin, Malcolm Cronlund, Edgar Haber, Kurt J. Bloch

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

We used a radioimmunoassay for fibrinopeptide A (FPA) to detect activation of blood clotting in patients with systemic lupus erythematosus (SLE). FPA levels were elevated in all patients with any degree of clinically detectable inflammation but were normal (< 1.5 ng/ml) or near normal in most patients in remission. The increase in concentration of plasma FPA varied directly with the number of organ systems that showed evidence of inflammation. In individual patients, changes in FPA preceded or closely paralleled changes in disease activity. We observed marked increases in FPA concentration prior to clinical exacerbations and marked decreases prior to drug-induced remissions. The activity of the clotting system as reflected by plasma FPA values appears to parallel the extent of inflammation and to provide a sensitive index of disease activity in patients with SLE.

Original languageEnglish (US)
Pages (from-to)430-436
Number of pages7
JournalThe American Journal of Medicine
Volume65
Issue number3
DOIs
StatePublished - Sep 1978

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Activation of blood clotting in patients with systemic lupus erythematosus. Relationship to disease activity'. Together they form a unique fingerprint.

  • Cite this